Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
197.32
-2.08 (-1.04%)
At close: Dec 15, 2025, 4:00 PM EST
198.00
+0.68 (0.34%)
Pre-market: Dec 16, 2025, 6:31 AM EST
Tenet Healthcare Revenue
Tenet Healthcare had revenue of $5.29B in the quarter ending September 30, 2025, with 3.18% growth. This brings the company's revenue in the last twelve months to $20.85B, down -0.64% year-over-year. In the year 2024, Tenet Healthcare had annual revenue of $20.68B with 0.54% growth.
Revenue (ttm)
$20.85B
Revenue Growth
-0.64%
P/S Ratio
0.87
Revenue / Employee
$212,714
Employees
98,000
Market Cap
17.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20.68B | 111.00M | 0.54% |
| Dec 31, 2023 | 20.56B | 1.20B | 6.18% |
| Dec 31, 2022 | 19.37B | -308.00M | -1.57% |
| Dec 31, 2021 | 19.68B | 1.15B | 6.23% |
| Dec 31, 2020 | 18.52B | 43.00M | 0.23% |
| Dec 31, 2019 | 18.48B | 166.00M | 0.91% |
| Dec 31, 2018 | 18.31B | -866.00M | -4.52% |
| Dec 31, 2017 | 19.18B | -442.00M | -2.25% |
| Dec 31, 2016 | 19.62B | 987.00M | 5.30% |
| Dec 31, 2015 | 18.63B | 2.03B | 12.23% |
| Dec 31, 2014 | 16.60B | 5.52B | 49.75% |
| Dec 31, 2013 | 11.09B | 1.97B | 21.58% |
| Dec 31, 2012 | 9.12B | 465.00M | 5.37% |
| Dec 31, 2011 | 8.65B | 389.00M | 4.71% |
| Dec 31, 2010 | 8.27B | -53.00M | -0.64% |
| Dec 31, 2009 | 8.32B | -267.00M | -3.11% |
| Dec 31, 2008 | 8.59B | 502.00M | 6.21% |
| Dec 31, 2007 | 8.08B | 339.00M | 4.38% |
| Dec 31, 2006 | 7.74B | -582.00M | -6.99% |
| Dec 31, 2005 | 8.33B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
THC News
- 12 days ago - Tenet Healthcare's Surge Isn't Over Yet - Seeking Alpha
- 5 weeks ago - Insurers Slide As Congress Postpones Decision On Health Subsidies, Delays Obamacare Subsidy Vote To December - Benzinga
- 6 weeks ago - Tenet Announces Upsizing and Pricing of Its $2.25 Billion Private Offerings of Senior Secured Notes and Senior Notes - Business Wire
- 6 weeks ago - Tenet Announces Private Offerings of Senior Secured Notes and Senior Notes to Refinance $2.0 Billion in Outstanding Notes - Business Wire
- 6 weeks ago - Tenet Healthcare Corporation (THC) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Tenet Reports Strong Third Quarter 2025 Results; Raises 2025 Financial Outlook - Business Wire
- 2 months ago - Tenet Healthcare: USPI Momentum Expected To Sustain Q3 Earnings, Why I Choose To Buy - Seeking Alpha
- 2 months ago - Tenet to Report Its Third Quarter 2025 Results on October 28th - Business Wire